enGene Inc. Warrants (ENGNW)
NASDAQ: ENGNW
· Real-Time Price · USD
0.66
-0.14 (-17.50%)
At close: May 06, 2025, 3:59 PM
0.61
-6.87%
After-hours: May 06, 2025, 07:53 PM EDT
-17.50% (1D)
| Bid | n/a |
| Market Cap | 33.39M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| EPS (ttm) | n/a |
| PE Ratio (ttm) | n/a |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | n/a |
| Volume | 11,131 |
| Avg. Volume (20D) | 7,672.404 |
| Open | 0.66 |
| Previous Close | 0.80 |
| Day's Range | 0.66 - 0.66 |
| 52-Week Range | 0.66 - 0.66 |
| Beta | -0.35 |
About ENGNW
enGene Holdings Inc., through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company that develops genetic medicines through the delivery of therapeutics to mucosal tissues and other organs. Its lead product candidate is EG-70 (detalimogene voraplasmid), which is a non-viral immunotherapy to treat non-muscle invasive bladder cancer patients with carcinoma-in-situ (Cis), who are unresponsive to treatment with Bacillus Calm...
Industry Biotechnology
Sector Healthcare
IPO Date n/a
Employees 56
Stock Exchange NASDAQ
Ticker Symbol ENGNW